Target intelligence / Profile preview

Fungal membrane and intracellular biosynthetic pathways

Molecular classification
Other
01

Overview

The term "Fungal membrane and intracellular biosynthetic pathways" refers to the collective molecular structures and metabolic processes in pathogenic fungi that are targeted by the secondary metabolites of the biocontrol fungus Clonostachys rosea (Sun et al., 2020, "Secondary metabolites from the mycoparasitic fungus Clonostachys rosea"). These targets primarily include the fungal cell membrane, which is disrupted by peptaibols—short, non-ribosomally synthesized peptides—that insert into the lipid bilayer to form ion channels or pores, leading to the leakage of essential ions and eventual cell death (Nygren et al., 2018, "The mycoparasitic fungus Clonostachys rosea responds to B. cinerea"). Additionally, C. rosea produces various polyketides and non-ribosomal peptides that interfere with intracellular biosynthetic pathways, such as those responsible for ergosterol synthesis and cell wall maintenance (Karlsson et al., 2015, "Insights into the Mycoparasitic Lifestyle of Clonostachys rosea"). By disrupting these essential systems, C. rosea effectively suppresses the growth and virulence of agricultural pathogens like Botrytis cinerea and Fusarium species. This multi-faceted mechanism of action makes these pathways critical focal points for understanding mycoparasitism and developing natural fungicidal agents for sustainable agriculture. However, because this entry describes a broad category of biological processes rather than a single protein or receptor, it is classified as a descriptive mechanism rather than a specific therapeutic target.

Other names
Fungal cell membraneFungal biosynthetic pathwaysMycoparasitic targets of Clonostachys roseaFungal metabolic pathways
02

Mechanism of action

Disruption of fungal membrane integrity through pore formation and inhibition of essential biosynthetic enzymes involved in ergosterol and cell wall synthesis.

03

Biological functions

Cell wall organizationMembrane integrityMetabolic processIon homeostasis
04

Disease associations

Infection
05

Safety considerations

Non-specific toxicity to non-target beneficial fungiPotential environmental persistence of secondary metabolitesRisk of resistance development in pathogenic fungi
06

Interacting drugs

Clonostachin

3 more in the full profile.

07

Biomarkers

Ergosterol concentrationCytoplasmic leakage markersChitin content

Beyond the preview

Go deeper on Fungal membrane and intracellular biosynthetic pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungal membrane and intracellular biosynthetic pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call